Index Entries

The SARS-CoV-2 Delta variant is poised to acquire complete resistance to wild-type spike vaccines

https://www.biorxiv.org/content/10.1101/2021.08.22.457114v1.full 

Yafei Liu, Noriko Arase, Jun-ichi Kishikawa, Mika Hirose, Songling Li, Asa Tada, Sumiko Matsuoka, Akemi Arakawa, Kanako Akamatsu, Chikako Ono, Hui Jin, Kazuki Kishida, Wataru Nakai, Masako Kohyama, Atsushi Nakagawa, Yoshiaki Yamagishi, Hironori Nakagami, Atsushi Kumanogoh, Yoshiharu Matsuura, Daron M. Standley, Takayuki Kato, Masato Okada, Manabu Fujimoto, and Hisashi Arase
August 22, 2021
Osaka University (Japan)

The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.

document
adverse events,COVID-19,vaccine (or viral) immune escape (VIE),vaccine systemic and virological concerns,vaccines